Skip to main content

Table 3 Fatty acid composition in liver and WAT of mice given control- or FPH-diets for 2 weeks and fasted over night

From: A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation

Fatty acids % (w/w)

Liver

WAT

 

Control

FPH

Control

FPH

∑ SFAs

34.57 ± 0.74

34.81 ± 0.87

32.35 ± 1.08

34.35 ± 1.15*

   C16:0

21.42 ± 0.35

22.19 ± 0.49*

25.26 ± 0.83

26.13 ± 1.31

   C18:0

12.02 ± 0.55

11.49 ± 0.57

4.61 ± 0.45

5.73 ± 0.55**

∑ MUFAs

25.43 ± 0.89

24.25 ± 1.31

48.62 ± 1.17

47.83 ± 2.35

   C16:1n-7

1.03 ± 0.13

1.03 ± 0.12

4.74 ± 0.34

4.51 ± 0.46

   C18:1n- 7

1.60 ± 0.08

1.32 ± 0.09***

2.22 ± 0.08

2.04 ± 0.04**

   C18:1n- 9

21.77 ± 0.75

21.01 ± 1.15

40.35 ± 1.40

40.08 ± 5.53

n- 6 PUFAs

31.05 ± 0.59

30.52 ± 0.07

17.61 ± 1.38

16.21 ± 1.35

   C18:2n-6

16.00 ± 0.54

17.03 ± 0.75*

16.70 ± 1.41

15.38 ± 1.30

   C20:3n- 6

0.90 ± 0.06

0.76 ± 0.05**

0.15 ± 0.01

0.12 ± 0.01*

   C20:4n- 6

12.96 ± 0.79

11.79 ± 0.57*

0.34 ± 0.04

0.30 ± 0.04

   C22:4n- 6

0.34 ± 0.01

0.25 ± 0.01***

0.07 ± 0.01

0.06 ± 0.01*

n- 3 PUFAs

8.73 ± 0.65

10.24 ± 0.68**

1.28 ± 0.10

1.49 ± 0.25

   C18:3n-3

0.42 ± 0.03

0.50 ± 0.05*

0.89 ± 0.06

0.98 ± 0.14

   C20:5n- 3 (EPA)

0.29 ± 0.03

0.57 ± 0.10***

0.03 ± 0.01

0.06 ± 0.02**

   C22:5n- 3

0.29 ± 0.02

0.42 ± 0.02***

0.07 ± 0.01

0.09 ± 0.02*

   C22:6n- 3 (DHA)

7.60 ± 0.65

8.60 ± 0.60*

0.24 ± 0.03

0.32 ± 0.07

n- 3:∑ n- 6 ratio

0.28 ± 0.35

0.34 ± 0.02**

0.07 ± 0.01

0.09 ± 0.01**

  1. Abbreviations: DHA docosahexaenoic acid, EPA eicosapentaenoic acid, FPH fish protein hydrolysate, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acids, SFA saturated fatty acids, WAT white adipose tissue.
  2. Data are means ± SD (n = 5). Values significantly different from control are indicated (*P < 0.05,**P < 0.01,***P < 0.001).